Patents
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
05/2001
05/23/2001EP1101491A2 Soft gelatine capsules containing olive oil
05/23/2001EP1101490A1 Preparation capable of releasing drug at target site in intestine
05/23/2001EP1101489A2 Sustained release heterodisperse hydrogel systems for insoluble drugs
05/23/2001EP1100892A1 Use of prohibitin rna in treatment of cancer
05/23/2001EP1100834A1 Polyanionic polymers which enhance fusogenicity
05/23/2001EP1100820A1 Pectic substance as a growth factor stabilizer
05/23/2001EP1100818A1 Inhibitors of hiv membrane fusion
05/23/2001EP1100803A2 Pyrrolo 2,1-b] 1,3]benzothiazepines with atypical antipsychotic activity
05/23/2001EP1100771A1 Compounds and compositions for delivering active agents
05/23/2001EP1100570A1 Apparatus for and methods of administering volatile substances into an inhalation flow path
05/23/2001EP1100549A2 A novel excipient for the lyophilization of aqueous suspensions of microparticles
05/23/2001EP1100548A2 Genetically engineered cells and tissues
05/23/2001EP1100540A1 Process for the preparation of granular and porous sucralfate dry gel
05/23/2001EP1100522A1 Pulmonary delivery of active agents
05/23/2001EP1100499A1 Prevention of migraine recurrence
05/23/2001EP1100491A1 Ophthalmic compositions for treating ocular hypertension
05/23/2001EP1100481A2 Pharmaceutical formulations comprising beclomethasone dipropionate for the treatment of inflammatory bowel disease
05/23/2001EP1100479A1 Medicinal products with retarded pharmacological activity and method for the production thereof
05/23/2001EP1100478A1 Estradiol-containing patch for transdermal administration of hormones
05/23/2001EP1100477A1 Estradiol-containing patch for transdermal administration of hormones
05/23/2001EP1100476A1 Formulations for the transdermal administration of fenoldopam
05/23/2001EP1100475A1 Use of drug-loaded nanoparticles for the treatment of cancers
05/23/2001EP1100474A2 Two-piece capsule for receiving pharmaceutical preparations for powder inhalers
05/23/2001EP1100473A2 Absorbable brachytherapy and chemotherapy delivery devices and methods
05/23/2001EP1100472A1 Pharmaceutical compositions comprising ibuprofen and domperidone
05/23/2001EP1100471A1 Compressed compositions comprising clarified xanthan gum
05/23/2001EP1100470A1 Fast dissolving ibuprofen containing compositions having analgesic activity
05/23/2001EP1100469A1 Rapidly disintegrable solid preparation
05/23/2001EP1100468A1 Microparticles with adsorbent surfaces, methods of making same, and uses thereof
05/23/2001EP1100467A1 Method for making coated gabapentine or pregabaline particles
05/23/2001EP1100466A1 Pharmaceutical composition having improved taste
05/23/2001EP1100465A1 Medicinal aerosol formulations
05/23/2001EP1100464A1 Lipid emulsion and solid lipid nanoparticle as a gene or drug carrier
05/23/2001EP1100463A1 New injectable formulations containing ramoplanin
05/23/2001EP1100462A2 Methods of ophthalmic administration
05/23/2001EP1100461A2 Method of vaccination of newly hatched poultry
05/23/2001EP1100460A1 A moldable solid delivery system
05/23/2001EP1100451A1 Topical moisture regulating compositions
05/23/2001EP1100433A1 Finely dispersed emulsifier-free systems of the oil-in-water and water-in-oil type, containing boron nitride
05/23/2001EP1100431A1 Finely dispersed emulsifier-free systems of the oil-in-water and water-in-oil type
05/23/2001EP1100407A1 Composition for freshening nostrils and sinus cavities
05/23/2001EP1100344A1 Novel chitosan-containing liquid compositions and methods for their preparation and use
05/23/2001EP0877761B1 Prion-free collagen and collagen-derived products and implants for multiple biomedical applications; methods of making thereof
05/23/2001EP0841897B1 Physically active antimicrobial gel for cosmetic products
05/23/2001DE19962221A1 Sustained-release medicament formulation, e.g. for parenteral or transdermal use, comprising drug and carrier system consisting of solid biodegradable blood plasma proteins obtained by fluidized bed drying
05/23/2001DE19956029A1 Active substance carrier system based on coating a substance with enzymatically cleavable side groups, useful for gene therapy especially of cancer and inflammation
05/23/2001CN2430885Y Face mask sticking cloth
05/23/2001CN1296516A Alkylene oxide polymer compositions
05/23/2001CN1296418A Controlled release tablet produced from linear water-insoluble polysaccharides
05/23/2001CN1296417A Preparation with controlled release
05/23/2001CN1296412A Formulation of fast-dissolving efavirenz capsules or tablets using super-disintegrants
05/23/2001CN1296407A Device for the transdermal delivery of dicolfenac
05/23/2001CN1296406A Pharmaceutial compositions
05/23/2001CN1295860A Traditional Chinese medicinal suppository fortreating rectal cancer
05/23/2001CN1295859A Process for preparation of medicine to treat diabetes
05/23/2001CN1295856A Syrup and granules for treating laryngopharyngitis and preparation process thereof
05/23/2001CN1295855A Compound Tournefortia monrana granules preparation and preparation thereof process
05/23/2001CN1295854A External plaster for treating cancer and preparation process thereof
05/23/2001CN1295848A Powder medicine for treating born and scald
05/23/2001CN1295845A Traditional Chinese medicine for treating burn and scald and preparation process thereof
05/23/2001CN1295841A Adhesive plaster for osteophytosis
05/23/2001CN1066065C Interferon solution
05/23/2001CN1066059C Psoriasis plaster
05/23/2001CN1066056C Ointment for treating red and swollen
05/23/2001CN1066055C Productive method for extracting flavonoid compound extract or powder from bamboo leaf
05/23/2001CN1066046C Plaster for treating rheumatism and preparation process thereof
05/23/2001CN1066045C Blood nourishing granules and preparation process thereof
05/23/2001CN1066043C Traditional Chinese medicinal for treating hyperosteogeny and prolapse of lumbar intervertebral disc
05/22/2001US6235781 Prostaglandin product
05/22/2001US6235756 Methods and compositions for inhibition of angiogenesis by thalidomide
05/22/2001US6235745 Use of 5HT3, antagonists for promoting intestinal lavage
05/22/2001US6235733 Aids therapy
05/22/2001US6235726 Preventing tissue adhesion
05/22/2001US6235725 Methods and compositions for the prevention of tolerance to medications
05/22/2001US6235724 Injections containing lipid a analogues and process for the preparation thereof
05/22/2001US6235722 Pharmacological preparation
05/22/2001US6235721 Oxidation resistance
05/22/2001US6235712 Non-aqueous polar aprotic peptide formulations
05/22/2001US6235710 Spray dried erythropoietin
05/22/2001US6235525 Nucleotide sequence; diagnosis; vaccines; transfected cell line
05/22/2001US6235318 Solid pieces of chewing gum, coating and covering
05/22/2001US6235313 Bioadhesive microspheres and their use as drug delivery and imaging systems
05/22/2001US6235312 Liquid crystalline phase drug delivery vehicle
05/22/2001US6235311 Pharmaceutical composition containing a combination of a statin and aspirin and method
05/22/2001US6235310 Methods of delivery using cationic lipids and helper lipids
05/22/2001US6235309 Selectin receptors and cells and ligands
05/22/2001US6235308 Hypotensive agents with intravenous administering lipospomes
05/22/2001US6235306 Solubility parameter based drug delivery system and method for altering drug saturation concentration
05/22/2001US6235303 Segmented capsules, coextrusion, interrupting injection, solidification of fibers
05/22/2001US6235302 Sponge cloth based on regenerated cellulose and with reinforced fibers
05/22/2001US6235282 Vaccinal fluid water-in-oil emulsions containing a metabolizable oil
05/22/2001US6235274 Microparticles which controllably release olfactorily active substances, methods of using same and processes for preparing same
05/22/2001US6235266 Dinucleotides useful for the treatment of lung disease
05/22/2001US6235224 Dissolving polymer in solvent, dissolving or dispersing agent to be encapsulated in said solvent, introducing mixture into nonsolvent to cause spontaneous formation of microencapsulated product
05/17/2001WO2001034827A1 Antisense modulation of rank expression
05/17/2001WO2001034801A2 Recombinant gelatin in vaccines
05/17/2001WO2001034700A1 Composition for hydrogel, hydrogel, and use thereof
05/17/2001WO2001034684A1 Microcrystalline cellulose cushioning granules
05/17/2001WO2001034677A1 Swelling and deswelling polymer blends
05/17/2001WO2001034647A2 Animal collagens and gelatins